BridgeBio Pharma Announces Filing of Registration Statement for Proposed Initial Public Offering
05.24.2019Eidos Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
11.06.2018Eidos Therapeutics to Host Conference Call and Webcast to Discuss Phase 2 Clinical Trial Results
10.29.2018
page of12